Relmada Therapeutics Statistics
Total Valuation
RLMD has a market cap or net worth of $698.57 million. The enterprise value is $605.56 million.
Important Dates
The last earnings date was Thursday, March 19, 2026, after market close.
| Earnings Date | Mar 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
RLMD has 104.89 million shares outstanding. The number of shares has increased by 30.89% in one year.
| Current Share Class | 104.89M |
| Shares Outstanding | 104.89M |
| Shares Change (YoY) | +30.89% |
| Shares Change (QoQ) | +84.07% |
| Owned by Insiders (%) | 4.68% |
| Owned by Institutions (%) | 42.36% |
| Float | 90.27M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 5.65 |
| P/TBV Ratio | 8.07 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.62
| Current Ratio | 14.62 |
| Quick Ratio | 14.46 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -94.05% and return on invested capital (ROIC) is -60.54%.
| Return on Equity (ROE) | -94.05% |
| Return on Assets (ROA) | -52.84% |
| Return on Invested Capital (ROIC) | -60.54% |
| Return on Capital Employed (ROCE) | -67.49% |
| Weighted Average Cost of Capital (WACC) | 8.25% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.38M |
| Employee Count | 17 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2,105.30% in the last 52 weeks. The beta is 0.73, so RLMD's price volatility has been lower than the market average.
| Beta (5Y) | 0.73 |
| 52-Week Price Change | +2,105.30% |
| 50-Day Moving Average | 4.65 |
| 200-Day Moving Average | 2.74 |
| Relative Strength Index (RSI) | 64.54 |
| Average Volume (20 Days) | 3,322,535 |
Short Selling Information
The latest short interest is 836,254, so 0.80% of the outstanding shares have been sold short.
| Short Interest | 836,254 |
| Short Previous Month | 1.11M |
| Short % of Shares Out | 0.80% |
| Short % of Float | 0.93% |
| Short Ratio (days to cover) | 0.62 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -59.10M |
| Pretax Income | -57.39M |
| Net Income | -57.39M |
| EBITDA | n/a |
| EBIT | -59.10M |
| Earnings Per Share (EPS) | -$1.45 |
Full Income Statement Balance Sheet
The company has $93.01 million in cash and n/a in debt, with a net cash position of $93.01 million or $0.89 per share.
| Cash & Cash Equivalents | 93.01M |
| Total Debt | n/a |
| Net Cash | 93.01M |
| Net Cash Per Share | $0.89 |
| Equity (Book Value) | 86.51M |
| Book Value Per Share | 1.18 |
| Working Capital | 87.55M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -45.79M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -45.79M |
| FCF Per Share | -$0.44 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
RLMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -30.89% |
| Shareholder Yield | -30.89% |
| Earnings Yield | -8.21% |
| FCF Yield | -6.55% |
Analyst Forecast
The average price target for RLMD is $12.40, which is 86.19% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.40 |
| Price Target Difference | 86.19% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -19.56% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 30, 2019. It was a reverse split with a ratio of 1:4.
| Last Split Date | Sep 30, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:4 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |